SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AlerisLife Inc. – ‘8-K’ for 9/19/22

On:  Monday, 9/19/22, at 8:13am ET   ·   For:  9/19/22   ·   Accession #:  1104659-22-101036   ·   File #:  1-16817

Previous ‘8-K’:  ‘8-K’ on / for 8/3/22   ·   Next:  ‘8-K’ on / for 10/17/22   ·   Latest:  ‘8-K’ on / for 3/20/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/19/22  AlerisLife Inc.                   8-K:5       9/19/22   10:186K                                   Toppan Merrill/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 5: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- tm2225850d1_8k_htm                  XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- fve-20220919_lab                      XML     96K 
 4: EX-101.PRE  XBRL Presentations -- fve-20220919_pre               XML     64K 
 2: EX-101.SCH  XBRL Schema -- fve-20220919                          XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
10: ZIP         XBRL Zipped Folder -- 0001104659-22-101036-xbrl      Zip     15K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0001159281  i false 0001159281 2022-09-19 2022-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  i September 19, 2022

 

 i AlerisLife Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 i Maryland    i 1-6817    i 04-3516029
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer Identification No.)

 

 i Two Newton Place

 i 255 Washington Street, Suite 300

 i Newton,  i Massachusetts

   i 02458
(Address of principal executive
offices)
  (Zip Code)

 

( i 617)  i 796-8387

  (Registrant’s telephone number, including area code)  

     

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading
Symbols
  Name of Each Exchange on Which
Registered
 i Common Stock    i ALR    i The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  i o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 C: 

 

 

 

Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The Board of Directors of AlerisLife Inc. (the “Company”) has appointed Heather Pereira as Senior Vice President, Chief Financial Officer and Treasurer of the Company, effective September 19, 2022. Ms. Pereira succeeds Jeffrey C. Leer, who will continue to serve as the Company’s President and Chief Executive Officer.

 

Prior to joining the Company, Ms. Pereira, 47, held financial and accounting roles of increasing responsibility at Acushnet Holdings Corp. (“Acushnet”) since 2004, including Vice President and Corporate Controller from May 2017 through August 2022 and Controller between May 2014 and May 2017. Prior to Acushnet, Ms. Pereira served as Accounting Manager at Cognos Incorporated from 2002 to 2004 and was an Associate at Arthur Andersen LLP from 2002 through 2004. Ms. Pereira is a certified public accountant and holds a Master of Science in Accountancy and a Master of Business Administration from Northeastern University.

 

Ms. Pereira has advised the Company that she has no arrangements or understandings with any other person pursuant to which she was appointed Senior Vice President, Chief Financial Officer and Treasurer.  She also advised the Company that she has no family relationships with any director, executive officer or any person nominated or chosen by the Company to become a director or executive officer of the Company.

 

Ms. Pereira’s annual base salary will be $285,000 and will receive a one-time $75,000 cash sign-on bonus. She will be eligible for additional bonuses and future share awards in amounts to be determined in the Company’s discretion.

 

 C: 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     AlerisLife Inc.
      
Date: September 19, 2022  By:  /s/ Jeffrey C. Leer
     Jeffrey C. Leer
     President and Chief Executive Officer

 

 C: 

 

 

 C: 

Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:9/19/22None on these Dates
 List all Filings 
Top
Filing Submission 0001104659-22-101036   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 1:21:09.1am ET